Add like
Add dislike
Add to saved papers

Long-term evaluation of patients undergoing laparoscopic antireflux surgery without bougie placement.

BACKGROUND: Laparoscopic antireflux surgery (LARS) has replaced the open approach in most centers and has become the standard surgical treatment of this disease. One of the controversial technical issues is whether to use a bougie or not at the time of wrap. The aim of the study was to evaluate the long-term consequences of LARS in a series of patients without bougie.

METHODS: An institutional review board-approved study was conducted for patients who underwent LARS between 1998 and 2005. Patients were contacted and an SF-12 form was completed. Their charts were reviewed. Patient characteristics, preoperative evaluation, intraoperative details, and postoperative course were studied.

RESULTS: Overall, 135 patients were identified who underwent LARS from 1998 to 2005 with no bougie. Only 123 patients could be contacted for the study. Preoperative work-up included EGD in 100%, manometry in 98%, and 24-hour pH study in 25% of patients. Postoperative dysphagia to solids was seen in 11 of 123 (8.9%) patients. One patient (<1%) had dysphagia to liquids. Five patients (4%) had severe dysphagia. EGD and dilatation was required in 5 of 123 (4%) patients. Ten patients (8.1%) had recurrent reflux requiring medication. Also, 4 of 123 (3.2%) patients had bloating symptoms and 2 of 123 (1.6%) patients had difficulty vomiting. The mean follow-up of patients was 38.6 months.

CONCLUSIONS: The overall rate of dysphagia in this series following LARS without bougie was 8.9%. Mild to moderate dysphagia was seen in 6 of 123 (4.8%) and 4% patients had severe dysphagia requiring dilatation. Endoscopic dilatation was successful in relieving symptoms in patients with severe dysphagia. The incidence of severe dysphagia reported in the literature is 2-5% and recurrent reflux 5-15%. Rate of dysphagia was comparable to other series reported in the literature, as was the rate of recurrent reflux. Based on our series of patients, LARS without bougie appears to be effective in terms of postoperative dysphagia and recurrent reflux.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app